Join us for this free webinar to hear three international experts from Spain, Norway and Japan discuss their experiences treating patients with Eyerising International’s patented repeated low-level red-light therapy (RLRL). The webinar will take place on Wednesday 20 November from 6:30pm AEDT.
First, Dr Aleksandar Stojanovic will take us through his hands-on experiences with RLRL in Norway and discuss the ongoing 12-month European real-world study.
Next, Dr Tae Igarashi-Yokoi will delve into the 12-month results of her trial on highly myopic children and, having introduced RLRL at Tokyo Medical and Dental University, will share her practical observations.
Finally, Dr Fernando Fernandez Velazquez will explore the six and 12-month results of his trial examining the adjunct use of RLRL with orthokeratology.
1.25 hours have been accredited by Optometry Australia (OA) and 1.25G by Optometrists and Dispensing Opticians Board (ODOB) in New Zealand.
Speakers
Dr Aleksandar Stojanovic is a renowned ophthalmologist and associate professor based in the University Hospital of North Norway. He has extensive expertise in paediatric refractive surgery, and frequently publishes in leading ophthalmology journals. Over the past year, he has been piloting repeated low-level red-light therapy in Norway as a member of Eyerising International’s Europe Advisory Board. He is now recruiting for the ongoing European real-world study of repeated low-level red-light therapy.
Dr Fernando Fernandez Velazquez is an acclaimed contact lens optometrist who is widely recognised in Spain for being the first to adopt orthokeratology and keratoconus techniques. Having previously trained across Spain, Boston and the United Kingdom, he has significant expertise in myopia control and is an active contributor to ophthalmic research. Over the past year, he has been piloting repeated low-level red-light therapy in his centre in Madrid, Spain, particularly focussing on the adjunct use of repeated low-level red-light therapy in his orthokeratology patients.
Dr Tae Igarashi-Yokoi is a distinguished paediatric ophthalmologist and associate professor based in Tokyo Medical and Dental University. She has vast experience in clinical research, with numerous peer-reviewed publications and international presentations to her name. Over the past two years, she has been collaborating with Professor Kyoko Ohno-Matsui of Tokyo Medical and Dental University on a trial of repeated low-level red-light therapy in highly myopic Japanese children.
Moderator
Andrew Kotsos B.Optom, PGCertOcTher is the founder and Managing Director of eyedea Consulting and a leader in Australian optometric education and continued professional development who has experience in content curation and execution of organisation-led education across different formats/channels. Mr Kotsos’ broad experience in clinical practice, accreditation and quality assurance, professional development and learning design is complemented by his strategic understanding and commercial acumen. He offers professional consultancy services to local, regional, and international industry clients, assisting them to meet project deliverables and key goals.
